The role of fructose in cancer cell metabolism provides a strong premise for our approach: genetically arming CAR-T cells with GLUT5 to facilitate fructose entry, which would allow them to exploit the abundance of fructose as an alternate fuel source in malignancies characterized by a fructose-rich and glucose-poor environment. The gene discussed is SLC2A5; the disease is cancer.